Physician profile

Hank Yang

Monterey Park, CA

NPI 1114946696

$48,503.03

in general payments reported to CMS, 2019-2025

75 companies · $5,379 in 2025

The $5,379 reported for 2025 was more than what 98% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$17,172.51
Consulting Fee$2,062.50
Education$526.02
Travel and Lodging$470.38

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Eisai INC. $6,268.89 2019-2023
Astrazeneca Pharmaceuticals Lp $3,889.92 2019-2025 Enhertu, Calquence, Imfinzi
Janssen Biotech, INC. $3,833.36 2019-2025 Darzalex, Tecvayli, Carvykti
Taiho Oncology, INC. $2,801.88 2022-2025
Exelixis INC. $2,659.07 2019-2025 Cabometyx
Abbvie INC. $2,525.99 2019-2025 Venclexta
Pfizer INC. $2,247.83 2019-2025
Novartis Pharmaceuticals Corporation $1,827.42 2019-2025
Genentech USA, INC. $1,554.86 2019-2025 Venclexta, Polivy, Lunsumio
Amgen INC. $1,355.83 2019-2023 Lumakras, Vectibix, Nplate
Genzyme Corporation $1,337.04 2019-2025
Lilly USA, LLC $1,303.26 2019-2025 Verzenio, Jaypirca, Retevmo
Gilead Sciences, INC. $1,262.09 2019-2025 Trodelvy
Incyte Corporation $1,153.30 2019-2025 Jakafi, Monjuvi, Pemazyre
Astellas Pharma US INC $1,077.63 2019-2025 Vyloy, Xospata, Padcev
Show all 75 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $1,063.41 2019-2025 Reblozyl, Opdivo, Augtyro
Celgene Corporation $945.39 2019-2025 Reblozyl, Opdualag, Opdivo
Glaxosmithkline, LLC. $822.64 2020-2025 Jemperli, Zejula, Ojjaara
Bayer Healthcare Pharmaceuticals INC. $775.69 2019-2025
Sobi, INC $735.03 2022-2025
Takeda Pharmaceuticals U.S.A., INC. $723.59 2019-2025 Fruzaqla, Ninlaro, Iclusig
Merck Sharp & Dohme LLC $696.96 2019-2025 Keytruda, Welireg, Lynparza
Emd Serono, INC. $646.83 2019-2025 Bavencio
Daiichi Sankyo INC. $610.16 2022-2025 Enhertu, Datroway
Pharmacyclics LLC, An Abbvie Company $512.91 2019-2023 Imbruvica
Regeneron Healthcare Solutions, INC. $403.98 2021-2025 Libtayo
Stemline Therapeutics INC. $383.74 2023-2025 Orserdu, Elzonris
Alexion Pharmaceuticals, INC. $372.66 2019-2024 Ultomiris
Nestle Healthcare Nutrition INC. $354.22 2021-2023
Pharmaessentia USA Corporation $325.09 2022-2025 Besremi
Dova Pharmaceuticals $281.62 2019-2021
Jazz Pharmaceuticals INC. $275.39 2022-2025 Zepzelca
Boehringer Ingelheim Pharmaceuticals, INC. $242.09 2019-2025 Gilotrif
Kite Pharma, INC. $238.04 2021-2025 Yescarta
Array Biopharma INC $235.78 2021-2025 Braftovi, Mektovi, Tukysa
Secura Bio, INC. $217.23 2020-2024 Copiktra
Deciphera Pharmaceuticals INC. $209.31 2022-2024 Qinlock
Seagen INC. $151.46 2022-2023 Tukysa, Adcetris, Padcev
Epizyme, INC. $134.35 2020-2021
Puma Biotechnology, INC. $130.85 2019-2024
Mirati Therapeutics, INC. $125.00 2023 Krazati
Alnylam Pharmaceuticals INC. $121.64 2021-2023 Givlaari
Verastem, INC. $118.72 2019
Clovis Oncology, INC. $113.61 2019
Karyopharm Therapeutics INC. $109.31 2022-2025 Xpovio
Blueprint Medicines Corporation $107.25 2022-2024 Ayvakit
Genmab U.S., INC. $102.37 2023-2025 Epkinly
Agios Pharmaceuticals, INC. $98.24 2024-2025 Pyrukynd
Ipsen Biopharmaceuticals, INC $85.43 2023-2024 Somatuline Depot, Onivyde
Beigene USA, INC. $82.12 2024 Brukinsa
Tersera Therapeutics LLC $77.45 2025 Zoladex
Rigel Pharmaceuticals, INC. $76.05 2022-2024 Rezlidhia, Tavalisse
Adc Therapeutics America, INC. $71.06 2023
Aadi Bioscience, INC. $46.75 2023 Fyarro
Dendreon Pharmaceuticals LLC $41.32 2023-2025 Provenge
Coherus Oncology, INC. $39.44 2024-2025 Loqtorzi
Aveo Pharmaceuticals, INC. $38.96 2025
Morphosys, US INC. $38.32 2021
Boston Scientific Corporation $37.01 2024 Therasphere Y90 Glass Microspheres 10 Gbq
Immunogen, INC. $35.62 2023 Elahere
Novocure INC. $34.29 2024 Optune Lua (Novottf-200t)
Macrogenics, INC. $30.95 2022
Iovance Biotherapeutics, INC. $30.71 2025 Amtagvi
Janssen Pharmaceuticals, INC $28.68 2019-2020
Springworks Therapeutics, INC. $27.09 2024 Ogsiveo
Pharmacosmos Therapeutics INC. $24.24 2022
Servier Pharmaceuticals LLC $24.04 2025
Apellis Pharmaceuticals, INC. $22.88 2023 Empaveli
Fennec Pharmaceuticals, INC. $22.73 2024 Pedmark
Immunomedics, INC. $22.37 2020
Cti Biopharma Corp. $21.07 2023 Vonjo
Sun Pharmaceutical Industries INC. $17.44 2019
Syndax Pharmaceuticals, INC. $16.54 2025
Menarini Silicon Biosystems, INC. $16.36 2024
Teva Pharmaceuticals USA, INC. $11.18 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Hank Yang

$48,503.03

in general payments reported 2019-2025

Years
2019-2025
Top company
Eisai INC.
Context
The $5,379 reported for 2025 was more than what 98% of providers received nationally.

https://glasscript.com/doctor/5056/hank-yang

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.